Skip to main content

Peer Review reports

From: TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients

Original Submission
30 Aug 2011 Submitted Original manuscript
3 Oct 2011 Reviewed Reviewer Report - M. Idrees
19 Oct 2011 Reviewed Reviewer Report - Saumitra Das
17 Dec 2011 Author responded Author comments - Hans Dieter Nischalke
Resubmission - Version 2
17 Dec 2011 Submitted Manuscript version 2
Publishing
8 Mar 2012 Editorially accepted
8 Mar 2012 Article published 10.1186/1471-2407-12-85

You can find further information about peer review here.

Back to article page